Related Experiment Video

Updated: Jul 10, 2026

Extracellular Vesicle Tissue Factor Activity Assay
03:53

Extracellular Vesicle Tissue Factor Activity Assay

Published on: December 29, 2023

The role of tissue factor pathway inhibitor-2 in cancer biology

Ewa Sierko1, Marek Z Wojtukiewicz, Walter Kisiel

  • 1Department of Oncology, Medical University, Bialystok, Poland.

Seminars in Thrombosis and Hemostasis
|November 15, 2007
PubMed

Insights

Tissue factor pathway inhibitor-2 (TFPI-2) expression is reduced in aggressive cancers due to aberrant methylation. Restoring TFPI-2 inhibits tumor growth, invasion, and metastasis, offering a potential new cancer therapy.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Oncology

Background:

  • Tissue factor pathway inhibitor-2 (TFPI-2) is a serine proteinase inhibitor structurally similar to TFPI.
  • TFPI-2 expression inversely correlates with tumor malignancy, suggesting a role in tumor suppression.
  • TFPI-2 inhibits key proteases and the TF/VIIa complex involved in coagulation and cancer progression.

Purpose of the Study:

  • To investigate the role of TFPI-2 in cancer biology and its potential as a therapeutic target.
  • To understand the mechanisms of TFPI-2 dysregulation in cancer, including aberrant methylation and alternative splicing.
  • To evaluate the impact of TFPI-2 restoration on tumor growth, invasion, angiogenesis, and metastasis.

Main Methods:

  • Analysis of TFPI-2 expression in normal and tumor tissues.
  • Investigation of TFPI-2 promoter methylation patterns in cancer cell lines.
  • Detection and characterization of aberrantly spliced TFPI-2 mRNA variants (asTFPI-2).
  • Assessment of TFPI-2's functional effects on tumor cell invasion, growth, apoptosis, and angiogenesis in vitro and in vivo.

Main Results:

  • TFPI-2 expression is diminished in malignant tumors, linked to aberrant promoter methylation and oncogenic upregulation of asTFPI-2.
  • TFPI-2 inhibits tumor invasiveness, growth, metastasis, angiogenesis, and promotes apoptosis.
  • Restoration of TFPI-2 expression in tumors suppressed these adverse processes.

Conclusions:

  • TFPI-2 plays a critical role in suppressing tumor development and progression.
  • Aberrant methylation and splicing of TFPI-2 contribute to cancer.
  • Restoring TFPI-2 expression represents a promising therapeutic strategy for various cancers.

More Related Videos

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells06:54

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells

Published on: October 27, 2020

Flow Cytometry Analysis of Tissue Factor Expression in Human Platelets10:08

Flow Cytometry Analysis of Tissue Factor Expression in Human Platelets

Published on: November 22, 2024

Related Concept Videos

Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...